SG Americas Securities LLC Has $13.24 Million Stock Holdings in Oscar Health, Inc. $OSCR

SG Americas Securities LLC lifted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 886.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 921,288 shares of the company’s stock after purchasing an additional 827,929 shares during the period. SG Americas Securities LLC owned 0.35% of Oscar Health worth $13,239,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Oscar Health by 2.1% in the third quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company’s stock valued at $381,636,000 after buying an additional 423,184 shares during the period. Thrive Capital Management LLC grew its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. American Century Companies Inc. grew its position in shares of Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock worth $100,298,000 after buying an additional 2,495,691 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Oscar Health by 0.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 3,718,765 shares of the company’s stock valued at $70,400,000 after acquiring an additional 31,785 shares in the last quarter. Finally, Farallon Capital Management LLC lifted its position in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock valued at $68,886,000 after acquiring an additional 2,163,000 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 76,962 shares of Oscar Health stock in a transaction on Tuesday, January 6th. The shares were sold at an average price of $17.01, for a total transaction of $1,309,123.62. Following the transaction, the insider directly owned 350,180 shares of the company’s stock, valued at $5,956,561.80. The trade was a 18.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 24.39% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of several research analyst reports. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a research note on Thursday, February 12th. Barclays set a $18.00 price objective on shares of Oscar Health and gave the company an “equal weight” rating in a report on Monday, January 5th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research note on Thursday, January 22nd. Finally, Stephens initiated coverage on Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.88.

Oscar Health Stock Performance

Shares of Oscar Health stock opened at $11.16 on Friday. Oscar Health, Inc. has a 52 week low of $11.05 and a 52 week high of $23.80. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44. The business has a 50 day moving average price of $13.64 and a 200-day moving average price of $16.09. The company has a market cap of $3.32 billion, a PE ratio of -6.41 and a beta of 1.91.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The company had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company’s quarterly revenue was up 17.3% compared to the same quarter last year. During the same quarter last year, the company posted ($0.62) EPS. Equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.